COMPANY

Jupiter Neurosciences

HQ: Jupiter, FL source · jupiterneurosciences.com ↗ · Southeast

EffRx was started as a vitamin company, but with the addition of Marshall Hayward, Jupiter Neurosciences CSO, invented, developed and received FDA and EU approvals of a drug treating osteoporosis, Binosto®. From company website Source · Oct 12, 2026

Keywords:

Location: Jupiter, FL · source · Sep 25, 2026

Profile checked Oct 10, 2026

$13.0MRaised (2 yrs)2NIH grants

Funding and NIH signals

SEC Form D raise Raised $775K (Form D filed Sep 4, 2026). SEC Form D 0001493152-26-041606 (Sep 4, 2026)
Evidence (1 event)
- Sep 4, 2026 · SEC Form D 0001493152-26-041606
  Name of Issuer: JUPITER NEUROSCIENCES, INC.; CIK: 1679628; Address: Palm Beach Gardens, FL; Submission type: D; Filing date: 2026-09-04; Industry Group: Other Health Care; Date of First Sale: 2026-08-20; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 774787; Total Amount Sold: 774787; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

May 21, 2026 Raise Follow-on offering — Registered direct: $2M (total, as published), announced May 21, 2026. Source: company release on GlobeNewswire. source ↗
Dec 4, 2024 Raise IPO: $11M (total, as published), announced Dec 4, 2024. Source: company release on GlobeNewswire. source ↗

Funding

Raised: $13.0M. Last 2 years.

May 21, 2026 Follow-on offering — Registered direct: $2M (total, as published), announced May 21, 2026. Source: company release on GlobeNewswire. source ↗
Dec 4, 2024 IPO: $11M (total, as published), announced Dec 4, 2024. Source: company release on GlobeNewswire. source ↗

NIH awards 2

Annual award amounts. Total $2.0M.

Apr 7, 2022 NIH award 3R44AG067907-01A1S1 FY2022: $233,281 awarded for that fiscal year; activity R44 (SBIR); PI HAYWARD, MARSHALL; recipient as written: JUPITER NEUROSCIENCES, INC., Jupiter, FL. Supplemental Funding for Grant N source ↗
Sep 16, 2020 NIH award 1R44AG067907-01A1 FY2020: $1,764,270 awarded for that fiscal year; activity R44 (SBIR); PI HAYWARD, MARSHALL; recipient as written: JUPITER NEUROSCIENCES, INC., Jupiter, FL. Safety and Pharmacokinetics of J source ↗